ICM Asset Management Inc. WA Takes Position in Myomo Inc (MYO)

ICM Asset Management Inc. WA bought a new stake in Myomo Inc (NYSEAMERICAN:MYO) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 266,000 shares of the company’s stock, valued at approximately $319,000. ICM Asset Management Inc. WA owned about 1.56% of Myomo at the end of the most recent quarter.

Separately, Bank of New York Mellon Corp grew its holdings in shares of Myomo by 87.7% in the 4th quarter. Bank of New York Mellon Corp now owns 46,925 shares of the company’s stock valued at $68,000 after buying an additional 21,925 shares during the period.

MYO has been the topic of several research reports. Zacks Investment Research cut shares of Myomo from a “hold” rating to a “sell” rating in a research report on Wednesday, December 26th. Roth Capital reaffirmed a “buy” rating on shares of Myomo in a research report on Tuesday, February 5th.

Shares of Myomo stock traded down $0.02 during trading on Monday, hitting $1.17. 57,080 shares of the stock were exchanged, compared to its average volume of 93,100. Myomo Inc has a 1-year low of $1.15 and a 1-year high of $4.30.

Myomo (NYSEAMERICAN:MYO) last announced its quarterly earnings results on Thursday, March 7th. The company reported ($0.22) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.23) by $0.01. The company had revenue of $0.89 million during the quarter, compared to analyst estimates of $0.70 million.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2019/04/15/icm-asset-management-inc-wa-takes-position-in-myomo-inc-myo.html.

About Myomo

Myomo, Inc, a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury.

Further Reading: Quiet Period Expirations

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.